ALXO financials

ALX Oncology (ALXO) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.

ALXO income statement, yearly

YearRevenueGross profitOperating incomeNet incomeEPS
2025––-$104.02M-$101.69M-1.90
2024––-$142.47M-$134.85M-2.58
2023––-$170.28M-$160.81M-3.74
2022$0.00–-$127.44M-$123.48M-3.03
2021$0.00–-$83.56M-$83.46M-2.07
2020$1.18M–-$43.66M-$50.94M-2.76